Targeting the protein kinase C family: are we there yet?

被引：316
|
作者：
Mackay, Helen J.
Twelves, Christopher J. [1 ]
机构：
[1] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England
[2] Univ Toronto, Princess Margaret Hosp, Dept Haematol & Med Oncol, Toronto, ON, Canada
来源：
NATURE REVIEWS CANCER | 2007年 / 7卷 / 07期
关键词：
BREAST-CANCER CELLS; ANTISENSE OLIGONUCLEOTIDE APRINOCARSEN; SIGNAL-TRANSDUCTION PATHWAYS; GLYCOGEN-SYNTHASE KINASE-3; PHASE-I TRIAL; BETA-II; MULTIDRUG-RESISTANCE; ALPHA EXPRESSION; GROWTH-FACTOR; BRYOSTATIN;
D O I：
10.1038/nrc2168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Protein kinase C (PKC) comprises a family of serine/ threonine kinases that are involved in the transduction of signals for cell proliferation, differentiation, apoptosis and angiogenesis. Unsurprisingly, disruption of PKC regulation is implicated in tumorigenesis and drug resistance. PKC function is complex in this context owing to the differing roles of individual isozymes within the cell and across tumour types. Therapeutically targeting PKC isozymes is not new; however, with many of the early PKC inhibitor cytotoxic drug combinations being discarded at the phase II level, and recent phase III studies in non-small-cell lung cancer proving negative, what's going wrong?
引用
收藏
页码：554 / 562
页数：9
相关论文
共 50 条
  • [41] C-reactive protein as a potential biomarker in psychiatric practice: Are we there yet?
    Baysak, Erensu
    Guden, Demet Sinem
    Aricioglu, Feyza
    Halaris, Angelos
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2022, 23 (04): : 243 - 256
  • [42] Protein kinase C and cancer: what we know and what we do not
    R Garg
    L G Benedetti
    M B Abera
    H Wang
    M Abba
    M G Kazanietz
    Oncogene, 2014, 33 : 5225 - 5237
  • [43] Protein kinase C and cancer: what we know and what we do not
    Garg, R.
    Benedetti, L. G.
    Abera, M. B.
    Wang, H.
    Abba, M.
    Kazanietz, M. G.
    ONCOGENE, 2014, 33 (45) : 5225 - 5237
  • [44] Are we there yet? Are we there yet?
    Conrad, Charles
    Malphurs, Ryan
    MANAGEMENT COMMUNICATION QUARTERLY, 2008, 22 (01) : 123 - 146
  • [45] Hepatitis C in 2019: Are We There Yet?
    Gardenier, Donald
    Olson, Mary C.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2019, 15 (06): : 415 - +
  • [46] Targeting of protein kinase C δ to mitochondria in the oxidative stress response
    Majumder, PK
    Mishra, NC
    Sun, XG
    Bharti, A
    Kharbanda, S
    Saxena, S
    Kufe, D
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (09): : 465 - 470
  • [47] Molecular Mechanisms Underlying Protein Kinase C Targeting To Mitochondria
    Yang, Zhaogang
    Hu, Keli
    CIRCULATION, 2010, 122 (21)
  • [48] Protein kinase C - A family of protein kinases, allosteric effectors or both?
    Cameron, Angus J. M.
    Parker, Peter J.
    ADVANCES IN ENZYME REGULATION, VOL 50, 2010, 50 : 169 - +
  • [49] A BIPARTITE NUCLEAR TARGETING MOTIF IN PROTEIN-KINASE-C
    MALVIYA, AN
    BLOCK, C
    TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (05) : 176 - 176
  • [50] Subspecies-specific targeting mechanism of protein kinase C
    Shirai, Y
    Sakai, N
    Saito, N
    JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (04): : 411 - 417
12345